Novel aminopyrimidine derivatives as PLK1 inhibitors
AssigneeBanyu Pharmaceutical Co., Ltd.
InventorsTakashi Hashihayata, Mikako Kawamura, Morihiro Mitsuya, Yoshiyuki Sato
Life of this patent
Estimating the term…
Loading patent…
AssigneeBanyu Pharmaceutical Co., Ltd.
InventorsTakashi Hashihayata, Mikako Kawamura, Morihiro Mitsuya, Yoshiyuki Sato
Estimating the term…
The present invention relates to a compound represented by Formula [I]: or a pharmaceutically acceptable salt or ester thereof, wherein R1 and R2, which may be the same or different, are each a hydrogen atom, a lower alkyl group, a cycloalkyl group, or the like; R3 and R4, which may be the same or different, are each a hydrogen atom, a lower alkyl group, NRaRb, a phenyl group, a lower alkyl group substituted with a phenyl group, a 4- to 7-membered aliphatic heterocyclic group, a lower alkyl group substituted with a 4- to 7-membered aliphatic heterocyclic group, a 5- or 6-membered aromatic heterocyclic group, a lower alkyl group substituted with a 5- or 6-membered aromatic heterocyclic group, or the like; and R5 is a hydrogen atom, a cyano group, a halogen atom, or a lower alkyl group.
A compound of Formula [I]:
Dependencies are inferred from the claim text.